You are here: Industry Insights > Covaxin

News List

Phase I clinical trial outcome shows Covaxin generates antibody, T-cell memory response expresspharma
December 24, 2020
Bharat Biotech’s COVID-19 vaccine Covaxin has shown positive long term antibody and T cell memory response in Phase I clinical trial.
Ocugen and Bharat Biotech to Co-develop COVAXIN for US market expresspharma
December 23, 2020
Companies will co-develop inactivated vaccine candidate, COVAXIN™, to prevent COVID-19 infection in the U.
COVAXIN is well tolerated with no serious adverse events in Phase I trials expresspharma
December 18, 2020
The trial was conducted on volunteers from diverse geographic locations and socioeconomic conditions, enrolling 375 participants across 11 hospitals.
Team of 70 Ambassadors and High Commissioners visit Bharat Biotech, discuss COVAXIN expresspharma
December 10, 2020
COVAXIN has been evaluated in approximately 1000 subjects in Phase I and Phase II clinical trials, with promising safety and immunogenicity results.
Bharat Biotech seeks EUA for Covaxin expresspharma
December 08, 2020
No date has been fixed as on when the SEC will meet for assessing and evaluating the applications, as per sources.
Modi visits key vaccine facilities as COVID-19 case load surges expresspharma
November 30, 2020
The companies are testing homegrown vaccine options, as well as working on trials of vaccines being developed overseas.
Homegrown COVID-19 vaccine final trials may conclude within two months: India expresspharma
November 24, 2020
ICMR and Bharat Biotech month started third-stage trials of COVAXIN, in a process that would involve 26,000 volunteers.
Bharat Biotech commences Phase III trials for COVAXIN expresspharma
November 17, 2020
Phase III trials will involve 26,000 volunteers across India who will receive two intramuscular injections, approximately 28 days apart.
AMU targets 1000 volunteers for phase-III trial of Covaxin expresspharma
November 12, 2020
Volunteers will be given transportation, and other care, as well as precautions, will be taken, as endorsed in the guidelines for clinical trials, assures university.
AMU targets 1000 volunteers for phase-III trial of Covaxin expresspharma
November 12, 2020
Volunteers will be given transportation, and other care, as well as precautions, will be taken, as endorsed in the guidelines for clinical trials, assures university.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page